Our Corporate Venture and Innovation team represents businesses and investors that are shaping the rapidly evolving health care technology landscape.
In an effort to foster and support innovation within the health care industry, we provide a broad range of legal and advisory services to entrepreneurs, emerging companies, angel investors, venture capital and corporate venture funds.
We also provide legal services that support large institutions engaging in technology development, investment, acquisition, partnership and collaborative transactions. With forward-thinking transaction leadership and a practical approach to counseling, we partner with our corporate venture clients to implement strategies that drive innovation and meet the client’s specific needs.
Our team supports numerous growing health care technology companies with trusted and dependable guidance throughout their life cycles. We provide the full complement of legal services and strategic guidance in support of:
- Entity formation, fundraising and venture financing matters
- Intellectual property development, acquisition and protection
- Strategic alliances, mergers and acquisitions, joint ventures, licensing arrangements and other critical transactions
- Employee compensation and benefits, human resources and talent management
- Corporate governance
- Initial public offerings and follow-on offerings
Our team also represents numerous angel investors, venture capital funds and corporate venture arms of large corporations actively involved in health care technology and innovation, and advise larger institutional clients in connection with acquisition, joint venture, strategic partnership and other collaboration and innovation transactions. Through these transactions our clients are able to transform internally and externally, expand into new markets, and gain competitive advantage by deploying new technologies, products and services.
A selection of our health care technology venture and innovation clients and projects is available below:
- Merck Global Health Innovation Fund in multiple strategic investments, including investments in Navigating Cancer, Ayogo Health, CareSync, MedHelp, Remedy Informatics and WellDoc.
- Merck Global Health Innovation Fund in its acquisition of Physicians Interactive, a leading provider of direct to physician and health care professional marketing.
- AbbVie BioVentures multiple strategic investments, including investments in eFFECTOR Therapeutics, a biopharmaceutical company developing translation regulators for the treatment of cancer, and Alector, a biotech company focused on Alzheimer’s disease and other neurodegenerative disorders.
- University of Pittsburgh Medical Center, in connection with venture investments and restructuring transactions.
- Symphony Health Solutions, a leader in health care data and analytics, in connection with debt financing, a spin-off transaction, corporate governance matters and HR-related matters.
- Tigerlabs Ventures, a digital health care-focused venture fund and accelerator, in connection with fund formation, investment matters and other general counsel services.
- SysTech International, a leader in technology development and deployment for brand identification and tracking focused on the pharmaceutical industry, in connection with equity and debt financings, corporate governance, intellectual property, litigation and other general counsel services.
- Physicians Interactive, a leading provider of direct to physician and health care professional marketing, in connection with debt financings, corporate governance, strategic partnerships and other general counsel services.
- ReSearch Pharmaceutical Services, a global next-generation clinical research organization, in its sale to Warburg Pincus.
- Pipeline Biomedical Holdings, Inc. in the sale of substantially all of its orthopedic medical device business to MAKO Surgical Corp.
- InfoLogix, Inc., a provider of enterprise mobility solutions for the health care and commercial industries, in its sale to Stanley Black & Decker, Inc.
- Inverness Graham, a private equity fund, in its acquisitions of TechDevice Corporation, MP&E and Advanced Cath, manufacturers of components for medical devices.
- Inverness Graham Investments, a private equity firm, in its sale of TechDevice Holdings, a Minnesota-based catheter company to a subsidiary of TE Connectivity.
- Connexin Software, the developer of the Office Practicum software product for pediatrician offices, in connection with an investment in Connexin by Bluff Point Associates.
- LLR Partners, a private equity fund, in its growth capital investments in IOD Incorporated, a health care information and service company, and Orbis Education, a health care education company.